Immuno-oncology Assays Market by Component (Consumables (Cytotoxicity Assays, MOA-Reflective Functional Assays for Co-Stimulatory and Inhibitory Checkpoint Receptors, Functional Assays, Custom, Others), Software Platform (Immunoassay, PCR, NGS, Flow Cytometry, Others)) by Technology (2D, 3D) by Technology (Natural Killer Cells, Macrophages, Dendritic Cells, Neutrophils, Fibroblasts, Others) by Application (Screen and Develop Antibodies, Small Molecules, Cellular Therapies (Chimeric Antigen Receptor T Cells (CAR-T), ADCC, ADCP, T Cell Redirection, Adoptive T Cell Therapy, Others) by Targets (PD-1, SIRPα, CTLA4, OX40, ICOS, Others) by Indication (Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, Other Cancers) by Usage (Research Solutions (Tumor Microenvironment and Immune Composition, Tumor Mutational Burden and Neoantigens, Cancer Microbiome Research, Immunotherapy Research Publications, Others) Others)); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028